Ensoma

未公开

Ensoma Inc expanding the reach of the curative power of Genomic medicine by pioneering a next-generation in vivo approach using its Ingenious Vectors.In January 2023, the company had entered into a definitive agreement to acquire Twelve Bio ApS. In February 2023, Ensoma Inc acquired Twelve Bio.In February 2021, Ensoma had entered into collaboration with Takeda Pharmaceutical Company Limited.In January 2023, Ensoma had completed series A financing of $85 million.In February 2021, Ensoma had announced $70 million in Series A financing,

https://ensoma.com/

470295

基本信息

公司全称

Ensoma Inc
类型

基因组药物研发商
产业领域

医药研发/制造、化学&生物药
公司人数

15~50人
地址

75 Kneeland Street,14Th Floor BOSTON MASSACHUSETTS 02111; US; Telephone: +16177663917;
联系电话
邮箱

info@ensoma.com
成立时间

2019-01-01

投融资

2025-09-22

未公开

Gilead Sciences

鱼鹰资管

Delos Capital

F-Prime Capital

Hanwha Impact Partners

Mirae Asset Financial Group

Qatar Investment Authority

RTW Investments

Solasta Ventures

Symbiosis

Viking Global Investors

5AM Ventures

Catalio Capital Management
2023-05-16

B轮

Bioluminescence Ventures

Kite Pharma

Delos Capital

Symbiosis Group

Gilead Sciences
2023-01-05

未透露

Alexandria Venture Investments

Catalio Capital Management

Mirae Asset Capital

Fred Hutchinson Cancer Center

Bill and Melinda Gates Foundation

Qatar Investment Authority

鱼鹰资管

Solasta Ventures

F-Prime Capital

Symbiosis Group

Takeda Ventures

Arix Bioscience

5AM Ventures

Viking Global Investors
2021-02-11

A轮

Alexandria Venture Investments

RIT Capital Partners

鱼鹰资管

F-Prime Capital

Takeda Ventures

5AM Ventures

Viking Global Investors
加载更多

Ensoma

基本信息

投融资

相关投融资企业